Skip to content
value.today

Prematics Inc.

🇺🇸 Vienna, Virginia, USAHealth CareFounded 2005
Total raised
$11 M
1 round on record
Latest round
$11 M
Mar 2009
First round on record
Mar 2009
Today
Private
No later event on record

Funding rounds

1 counted as startup funding. Open the number of investors for the round's details.

Funding rounds of Prematics Inc.
MonthRaisedRaiseSizeInvestorsSoldFiling
Mar 2009$11 MNo. 1$10 to $50 million

Prematics Inc.: Raise no. 1, Mar 2009

Investors in this round

8 investors had bought by the notice of Apr 7, 2009: 8 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$11 M of $12 M offered; $1 M still to sell
Smallest investment taken
no minimum stated
What was sold
equity
Exemption claimed
  • 06
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
Estimates
the notice marks payments to its own people as estimates
The company
Corporation, incorporated in De

People named in the notice

  • Kevin Hutchinson · Executive Officer, Director
  • Anthony Masso · Director
  • David Brailer · Director
  • James Bradley · Director
  • Kenneth Novack · Director
  • Richard Redelfs · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Remarks in the notice

  • On the amounts: “Total offering amount includes up to $12,000,000.40 worth of Series C Preferred Stock to be sold.”

Signed by Kevin Hutchinson, President and Chief Executive Officer. Source: SEC Form D, newest notice filed Apr 7, 2009. Read the notice at the SEC.

equitySEC

Source: SEC Form D. Each row is one private sale of securities with the running total of its newest notice. The form does not name the series or the investors; rounds are numbered in the order they were filed. A round's details show what its notice does say: accredited and other investors, the smallest investment taken, the exemption claimed, fees, the people named and the brokers paid to sell it.

How it makes money#

What its filings and its own website say, sentence by sentence, each with its source.

  • Prematics Inc. chose not to state its revenue in its newest notice of a funding round (Apr 2009).

    SEC Form D · Apr 2009

  • The industry group it chose in its notices: Other Health Care.

    SEC Form D · Apr 2009

That is all the official record says: Prematics Inc. has not published its revenue in a filing we can read, and no other official source covers it. Revenue figures come from crowdfunding filings (SEC Form C) and from annual reports once a company is listed.

Products and services#

No products or services on record: no website is on record for it in an official source (its SEC filings, Wikidata).

Investors#

No investor of Prematics Inc. is named in an official source we use. Its funding notices give only how many investors bought, not who they are.

Source: SEC Form 3 statements, SEC Form N-PORT fund reports, Wikidata, value.today research. Names come from filings that do name holders: the preferred stock each holder had when the company registered its shares (Form 3), private shares in US mutual funds' portfolio reports (N-PORT), and Wikidata. None ties a name to one funding round, so this list is per company, and it is not complete: the 1 round above had up to 8 investors.

Executives and directors

As the company named them in its notices. Directors of a funded startup are often partners of its investors.

People named by Prematics Inc.
NameRoleNamed in
Kevin HutchinsonExecutive officerApr 2009
Anthony MassoDirectorApr 2009
David BrailerDirectorApr 2009
James BradleyDirectorApr 2009
Kenneth NovackDirectorApr 2009
Kevin HutchinsonDirectorApr 2009
Richard RedelfsDirectorApr 2009